Drug Trial Radar · NCT06680505
Safety and Efficacy Study of YZJ-1139 in Primary Chronic Insomnia Disorder
Last checked: Nov 20, 2026Latest source record: Nov 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
300
Actual
Start
Aug 4, 2019
Primary completion
Sep 30, 2020
Study completion Mar 29, 2021
Sponsor
- Lead sponsor
- Shanghai Haiyan Pharmaceutical Technology Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Nov 8, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to evaluate the efficacy and safety of YZJ-1139 in the short-term treatment of primary chronic insomnia, explore the optimal effective dose, and provide the basis for phase III clinical trials
Conditions
- Insomnia Disorder
Interventions
YZJ-1139 10mgDrug
YZJ-1139 10mg tablets
YZJ-1139 20mgDrug
YZJ-1139 20mg tablets
YZJ-1139 40mgDrug
YZJ-1139 40mg tablets
YZJ-1139 60mgDrug
YZJ-1139 60mg tablets
PlaceboDrug
Match placebo tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sleep efficiency (SE) monitored by PSGTime frame: Baseline , for all subjects: Day 1 / Day 2,Day 13 / Day 14; for 1/5 subjects: Day 27 / Day 28
Locations
33 sites in 1 country. Site status is shown where the registry gives one.
Beijing HuiLongGuan Hospital
Beijing, China
Peking University People's Hospital
Beijing, China
Xuanwu Hospital, Capital Medical University
Beijing, China
The First Affiliated Hospital of Bengbu Medical College
Bengbu, China
The First Hospital of Jilin University
Changchun, China
Hunan Brain Hospital
Changsha, China
Xiangya Hospital, Central South University
Changsha, China
West China Hospital, Sichuan University
Chengdu, China
Army Specialty Medical Center
Chongqing, China
Guangdong Provincial People's Hospital
Guangzhou, China
Nanfang Hospital of Southern Medical University (Department of Psychiatry)
Guangzhou, China
Nanfang Hospital, Southern Medical University (Sleep Medicine Center)
Guangzhou, China
The First Affiliated Hospital of Jinan University
Guangzhou, China
The Second Affiliated Hospital of Anhui Medical University
Hefei, China
The Affiliated Hospital of Jiujiang University
Jiujiang, China
The First Affiliated Hospital of Kunming Medical University
Kunming, China
The First People's Hospital of Yunnan Province
Kunming, China
Jiangxi Provincial Psychiatric Hospital
Nanchang, China
Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing
Nanjing, China
The First People 's Hospital of Nantong
Nantong, China
Qingdao Municipal Hospital
Qingdao, China
The Second Affiliated Hospital of Fujian Medical University
Quanzhou, China
Huashan Hospital Affiliated to Fudan University
Shanghai, China
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China
The First Hospital of Hebei Medical University
Shijiazhuang, China
The Third Hospital of Hebei Medical University
Shijiazhuang, China
The Second Affiliated Hospital of Soochow University
Suzhou, China
Tianjin Anding Hospital
Tianjin, China
Wuhan Mental Health Center
Wuhan, China
Tangdu Hospital, Fourth Military Medical University, PLA
Xi'an, China
The Second Affiliated Hospital of Xinxiang Medical University
Xinxiang, China
Henan Provincial People's Hospital
Zhengzhou, China
The Affiliated Hospital of Zunyi Medical College
Zunyi, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.